Cargando…
Novel potential therapeutic targets of alopecia areata
Alopecia areata (AA) is a non-scarring hair loss disorder caused by autoimmunity. The immune collapse of the hair follicle, where interferon-gamma (IFN-γ) and CD8+ T cells accumulate, is a key factor in AA. However, the exact functional mechanism remains unclear. Therefore, AA treatment has poor eff...
Autores principales: | Xu, Wen, Wan, Sheng, Xie, Bo, Song, Xiuzu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154608/ https://www.ncbi.nlm.nih.gov/pubmed/37153617 http://dx.doi.org/10.3389/fimmu.2023.1148359 |
Ejemplares similares
-
The potential of regulatory T cell-based therapies for alopecia areata
por: Wan, Sheng, et al.
Publicado: (2023) -
Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
por: Wei, Dongfan, et al.
Publicado: (2023) -
Alopecia areata induced by the booster shot of Sinovac COVID-19 vaccination: a case report
por: Wu, Yi, et al.
Publicado: (2023) -
Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
por: Ramírez-Marín, Hassiel Aurelio, et al.
Publicado: (2022) -
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)